Logo image of CBUS

CIBUS INC (CBUS) Stock Price, Quote, News and Overview

NASDAQ:CBUS - Nasdaq - US17166A1016 - Common Stock - Currency: USD

1.5  +0.03 (+2.04%)

After market: 1.59 +0.09 (+6%)

CBUS Quote, Performance and Key Statistics

CIBUS INC

NASDAQ:CBUS (6/20/2025, 4:53:39 PM)

After market: 1.59 +0.09 (+6%)

1.5

+0.03 (+2.04%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High10.77
52 Week Low1.4
Market Cap51.57M
Shares34.38M
Float26.81M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-06 2025-08-06
IPO07-20 2017-07-20


CBUS short term performance overview.The bars show the price performance of CBUS in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40

CBUS long term performance overview.The bars show the price performance of CBUS in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of CBUS is 1.5 USD. In the past month the price decreased by -45.45%. In the past year, price decreased by -85%.

CIBUS INC / CBUS Daily stock chart

CBUS Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 18.04 327.31B
AMGN AMGEN INC 13.94 155.58B
GILD GILEAD SCIENCES INC 14.02 134.97B
VRTX VERTEX PHARMACEUTICALS INC N/A 113.22B
REGN REGENERON PHARMACEUTICALS 11.5 55.03B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 40.38B
ARGX ARGENX SE - ADR 94.29 33.10B
ONC BEONE MEDICINES LTD-ADR 6.33 26.73B
BNTX BIONTECH SE-ADR N/A 25.61B
NTRA NATERA INC N/A 23.47B
INSM INSMED INC N/A 18.70B
BIIB BIOGEN INC 8.03 18.62B

About CBUS

Company Profile

CBUS logo image Cibus, Inc. engages in the research and development of plant traits to seed companies for royalties. The company is headquartered in San Diego, California and currently employs 157 full-time employees. The company went IPO on 2017-07-20. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). The company is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. The company has a pipeline of five productivity traits. The company has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.

Company Info

CIBUS INC

6455 Nancy Ridge Drive

San Diego CALIFORNIA US

Employees: 158

CBUS Company Website

CBUS Investor Relations

Phone: 18584500008

CIBUS INC / CBUS FAQ

What is the stock price of CIBUS INC today?

The current stock price of CBUS is 1.5 USD. The price increased by 2.04% in the last trading session.


What is the ticker symbol for CIBUS INC stock?

The exchange symbol of CIBUS INC is CBUS and it is listed on the Nasdaq exchange.


On which exchange is CBUS stock listed?

CBUS stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for CIBUS INC stock?

10 analysts have analysed CBUS and the average price target is 17.34 USD. This implies a price increase of 1056% is expected in the next year compared to the current price of 1.5. Check the CIBUS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is CIBUS INC worth?

CIBUS INC (CBUS) has a market capitalization of 51.57M USD. This makes CBUS a Micro Cap stock.


How many employees does CIBUS INC have?

CIBUS INC (CBUS) currently has 158 employees.


What are the support and resistance levels for CIBUS INC (CBUS) stock?

CIBUS INC (CBUS) has a resistance level at 2.28. Check the full technical report for a detailed analysis of CBUS support and resistance levels.


Is CIBUS INC (CBUS) expected to grow?

The Revenue of CIBUS INC (CBUS) is expected to grow by 34.19% in the next year. Check the estimates tab for more information on the CBUS EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy CIBUS INC (CBUS) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does CIBUS INC (CBUS) stock pay dividends?

CBUS does not pay a dividend.


When does CIBUS INC (CBUS) report earnings?

CIBUS INC (CBUS) will report earnings on 2025-08-06.


What is the Price/Earnings (PE) ratio of CIBUS INC (CBUS)?

CIBUS INC (CBUS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.69).


What is the Short Interest ratio of CIBUS INC (CBUS) stock?

The outstanding short interest for CIBUS INC (CBUS) is 6.53% of its float. Check the ownership tab for more information on the CBUS short interest.


CBUS Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

CBUS Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to CBUS. CBUS may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CBUS Financial Highlights

Over the last trailing twelve months CBUS reported a non-GAAP Earnings per Share(EPS) of -2.69. The EPS increased by 85.34% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -82.03%
ROE -391.1%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%33.93%
Sales Q2Q%89.72%
EPS 1Y (TTM)85.34%
Revenue 1Y (TTM)104.08%

CBUS Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 80% to CBUS. The Buy consensus is the average rating of analysts ratings from 10 analysts.

For the next year, analysts expect an EPS growth of 10.29% and a revenue growth 34.19% for CBUS


Ownership
Inst Owners24.56%
Ins Owners8.71%
Short Float %6.53%
Short Ratio5.05
Analysts
Analysts80
Price Target17.34 (1056%)
EPS Next Y10.29%
Revenue Next Year34.19%